openPR Logo
Press release

Global HIV/AIDS Diagnostics Market will Likely Expand at a 9.3% CAGR from 2017 to 2025

01-31-2018 01:54 PM CET | Health & Medicine

Press release from: Transparency Market Research

Global HIV/AIDS Diagnostics Market will Likely Expand at a 9.3%

The global HIV/AIDS diagnostics market has a handful of dominant players competing against one another. Competition is moderate in the market on account of a few products being approved for commercial use. In fact, all the products in the U.S. are used only for the purpose of research. Another factor serving to keep competition moderate is the high entry barriers to aspiring players. This is because development of diagnostic kits require a lot of research. Going forward, however, the competition may intensify because of the competitive pricing strategy adopted by key companies.

F. Hoffman-La Roche Ltd., Alere, Abbott Laboratories, OraSure Technologies, Inc., Becton, Dickinson and Company, and Siemens Healthineers are to name a few key companies operating in the global HIV/AIDS diagnostics market. While some of them have expanded their shares through mergers and acquisitions, others have made impressive strides through research and development and introduction of new products.

Obtain Report Details @ https://www.transparencymarketresearch.com/hiv-aids-diagnostics-market.html

As per a report by Transparency Market Research, the global HIV/AIDS diagnostics market will likely expand at a 9.3% CAGR between 2017 and 2025 to become worth US$5.74 bn by 2025 from US$2.606 bn in 2016.

Ability to Yield Swift, Accurate Results Make Rapid Test (POC) Market Leading Segment

The three types of tests used in the global HIV/AIDS diagnostics market are rapid tests (POC), ELISA, and nucleic acid test, among others. Of them, the segment of rapid test (POC) accounts for maximum market share. It was worth US1.526 bn in 2016, finds the report by TMR. The test is popular on account its easy usage and swift results. In the near future too, the segment of rapid test (POC) is predicted to hold on to its dominant share due to its relative affordability and ability to produce accurate results faster.

Geographically, the key segments of the global HIV/AIDS diagnostics market are North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. At present, North America dominates the market with a leading share. In the upcoming years too, the region is expected to hold on to its dominant share by expanding at a CAGR of 8.7% from 2017 to 2025. This is mainly because of the increasing awareness about the different diagnosis, initiatives by government to thwart HIV, and superior research and development facilities.

Download Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=26582

Increasing Instances of HIV Fuelling Market Majorly

Alarming rise in occurrence of HIV worldwide and the growing awareness about diagnosis is said to be the root cause of growth in the global HIV/AIDS diagnostics market. “A release by the Joint United Nations Programme on HIV/AIDS (UNAIDS) in 2015, showed that an estimated 36.7 mn people were living with HIV, and the prevalence rate of HIV was 0.8% worldwide. Most of the HIV-afflicted people live in low and middle income countries. To tackle the menace, government organizations and agencies are focusing on public awareness campaigns about diagnosis, treatment, and care,” elaborates the lead analyst of the TMR report.

In many cases HIV is asymptomatic, which means even though the immune system is gradually getting affected, there is no outward signs. Many people can go without the symptoms, and hence without realizing they have HIV, for as long as 10 years. This is posing a roadblock to the global HIV/AIDS diagnosis market.

Pre-Book Full Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=26582<ype=S

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global HIV/AIDS Diagnostics Market will Likely Expand at a 9.3% CAGR from 2017 to 2025 here

News-ID: 924942 • Views:

More Releases from Transparency Market Research

Autoinjectors Market to be Worth USD 173.9 Bn by 2036 - By Usability / By Route of Administration / By End-user | U.S. • U.K. • Japan • Brazil
Autoinjectors Market to be Worth USD 173.9 Bn by 2036 - By Usability / By Route …
The global autoinjectors market has emerged as a vital segment within the injectable drug delivery ecosystem, demonstrating robust expansion supported by technological innovation and the increasing prevalence of chronic diseases worldwide. The market was valued at US$ 89.9 billion in 2025 and is projected to reach US$ 173.9 billion by 2036, registering a compound annual growth rate (CAGR) of 6.2% from 2026 to 2036. Preview crucial insights and findings from our
Argentina Car Care Products Market Outlook 2036: Market Size to Reach US$ 960.6 Million, Driven by Vehicle Aging, Professional Detailing Expansion, and Premium Product Innovation
Argentina Car Care Products Market Outlook 2036: Market Size to Reach US$ 960.6 …
The Argentina car care products market continues to demonstrate steady, resilient growth, reflecting the country's large and aging vehicle fleet and rising consumer awareness around vehicle aesthetics and resale value. In 2025, the market was valued at US$ 641.1 million and is projected to expand to US$ 960.6 million by 2036, registering a compound annual growth rate (CAGR) of 3.8% from 2026 to 2036. This growth trajectory underscores the essential nature
Dental 3D Printing Market Outlook 2036: Explosive 26.3% CAGR Growth Driven by Customization, CAD/CAM Integration, and Aesthetic Dentistry Demand
Dental 3D Printing Market Outlook 2036: Explosive 26.3% CAGR Growth Driven by Cu …
The global dental 3D printing market is entering a phase of extraordinary expansion. Valued at US$ 5.1 Bn in 2025, the market is projected to surge to US$ 66.1 Bn by 2036, registering a robust compound annual growth rate (CAGR) of 26.3% from 2026 to 2036. This rapid growth reflects the accelerating shift of dental practices and laboratories toward digital, patient-specific manufacturing solutions. Such a steep growth curve positions dental 3D
Chromoendoscopy Agents Market Outlook 2036: Rising GI Disorder Burden and Advanced Endoscopic Diagnostics Driving Steady Growth
Chromoendoscopy Agents Market Outlook 2036: Rising GI Disorder Burden and Advanc …
The global chromoendoscopy agents market was valued at US$ 0.16 billion in 2025 and is projected to reach US$ 0.28 billion by 2036, expanding at a CAGR of 5.2% from 2026 to 2036. The market is witnessing consistent growth due to the rising prevalence of gastrointestinal (GI) disorders, increasing demand for early cancer detection, and growing adoption of advanced endoscopic diagnostic techniques in hospitals and specialty clinics worldwide. Get Your Sample

All 5 Releases


More Releases for HIV

HIV Drugs Market - Defeating HIV Together: Advancing Treatment Options for a Bri …
Newark, New Castle, USA: The "HIV Drugs Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors HIV Drugs Market: https://www.growthplusreports.com/report/hiv-drugs-market/7792 This latest report researches the industry structure, sales, revenue,
HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Introduction to Human Immunodeficiency Virus (HIV) Vaccines 1.1 Overview 1.2 Antiquity of HIV Vaccine Need for the Development of HIV Vaccine Primer of HIV inside the Body 3.1 Inclusion of HIV Virus into the System 3.2 Interaction of HIV with Host 3.3 Eradication of HIV Virus HIV Vaccine Development Process 4.1 Introduction
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways